 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.032.635 |
| Chemical and physical data | |
| Formula | C23H25N |
| Molar mass | 315.460 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Fendiline is anonselectivecalcium channel blocker andcoronary vasodilator, originally developed for itsanti-anginal andantiarrhythmic properties in the management ofcoronary heart disease.[1][2][3]
By inhibiting the influx ofcalcium ions into cardiac and vascularsmooth muscle cells, fendiline promotes vasodilation, particularly of the coronary arteries, thereby increasing blood flow to the heart muscle, alleviating ischemia, and reducing chest pain associated with angina.[2] Although its clinical use has become limited due to the availability of alternative treatments and its relatively slow onset of action, fendiline remains notable for its long half-life, lack of tolerance development, and demonstrated efficacy in improving exercise tolerance and reducing the frequency of angina attacks in placebo-controlled trials.[2]
 | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it. |